TIMM23: A Drug Target / Disease Biomarker (G100287932)

Target Name: TIMM23

NCBI ID: G100287932

TIMM23

TIMM23: A Drug Target / Disease Biomarker

TIMM23 is a protein that is expressed in the brain and is involved in the development and progression of several neurological disorders, including Alzheimer's disease. It is also a potential drug target for several diseases, including cancer.

TIMM23 is a transmembrane protein that is expressed in the brain and is involved in the development and progression of several neurological disorders, including Alzheimer's disease. It is also a potential drug target for several diseases, including cancer.

One of the most promising aspects of TIMM23 is its potential as a drug target. Researchers have identified several potential drug candidates that can interact with TIMM23 and are currently in the process of testing them in preclinical studies.

One of the most promising aspects of TIMM23 is its potential as a drug target. Researchers have identified several potential drug candidates that can interact with TIMM23 and are currently in the process of testing them in preclinical studies.

One of the most promising aspects of TIMM23 is its potential as a drug target. Researchers have identified several potential drug candidates that can interact with TIMM23 and are currently in the process of testing them in preclinical studies.

One of the most promising aspects of TIMM23 is its potential as a drug target. Researchers have identified several potential drug candidates that can interact with TIMM23 and are currently in the process of testing them in preclinical studies.

TIMM23 is a transmembrane protein that is expressed in the brain and is involved in the development and progression of several neurological disorders, including Alzheimer's disease. It is also known as Tau-associated protein 23 and is composed of 215 amino acids.

TIMM23 is a transmembrane protein that is expressed in the brain and is involved in the development and progression of several neurological disorders, including Alzheimer's disease. It is also known as Tau-associated protein 23 and is composed of 215 amino acids.

TIMM23 is involved in the formation of neurotransmitter receptors and in the regulation of neurotransmitter signaling. It is also involved in the regulation of pain perception and in the development of neurodegenerative diseases.

TIMM23 is involved in the formation of neurotransmitter receptors and in the regulation of neurotransmitter signaling. It is also involved in the regulation of pain perception and in the development of neurodegenerative diseases.

TIMM23 is a potential drug target for several diseases, including cancer. Studies have shown that TIMM23 can interact with several proteins, including the protein p53. This suggests that TIMM23 may be a useful target for cancer treatments.

TIMM23 is a potential drug target for several diseases, including cancer. Studies have shown that TIMM23 can interact with several proteins, including the protein p53. This suggests that TIMM23 may be a useful target for cancer treatments.

TIMM23 has also been shown to interact with several other proteins, including the protein USP90. This suggests that TIMM23 may be a useful target for diseases that are caused by the overproduction or decreased production of proteins.

TIMM23 has also been shown to interact with several other proteins, including the protein USP90. This suggests that TIMM23 may be a useful target for diseases that are caused by the overproduction or decreased production of proteins.

In conclusion, TIMM23 is a protein that is expressed in the brain and is involved in the development and progression of several neurological disorders, including Alzheimer's disease. It is also a potential drug target for several diseases, including cancer. The identification of potential drug candidates that can interact with TIMM23 is an exciting development in the field of neurodegenerative diseases. Further research is needed to fully understand the role of TIMM23 as a drug target and to develop effective treatments for the disorders associated with its dysfunction.

Protein Name: Translocase Of Inner Mitochondrial Membrane 23

Functions: Essential component of the TIM23 complex, a complex that mediates the translocation of transit peptide-containing proteins across the mitochondrial inner membrane

The "TIMM23 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TIMM23 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets